Emerging Company Profile

With crossover funding already in place, Stagliano’s Neuron23 exits stealth with programs in neurology, systemic immune disease

Emerging Company Profile: Westlake Village start-up’s partnership with Germany’s Origenis yields candidates against two targets

A partnership with Germany’s Origenis gives the Westlake Village-backed biotech candidates against two targets.

After two years in